Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia

Key facts

Sponsor

Medipost Co Ltd.

Principal Investigator

Won-Soon Park, M.D., PhD.

Samsung Medical Center

Intervention

Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells(biological)

Enrollment

9 enrolled

Eligibility

All sexes

Timeline

2010 – 2011

Study locations (1)

• Samsung Medical Center, Seoul, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT06373289
  Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
  University of Alabama at Birmingham
• RECRUITINGNCT07109791
  National Surveillance and Prevention of Neonatal VAP
  University of Alberta
• RECRUITINGPHASE2NCT07561125
  Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
  International Peace Maternity and Child Health Hospital
• RECRUITINGPHASE2NCT06915441
  Lipid Infusions to Optimize Nutrition Trial
  The University of Texas Health Science Center, Houston
• RECRUITINGPHASE1, PHASE2NCT07101640
  PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
  Duke University
• RECRUITINGNCT07273643
  Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality
  University Hospital, Montpellier
• RECRUITINGEARLY PHASE1NCT07120971
  Metformin for Premature Infants With Bronchopulmonary Dysplasia
  Medical College of Wisconsin
• RECRUITINGNCT07134387
  Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)
  Global Foundation for the Care of Newborn Infants

See all trials for Bronchopulmonary dysplasia →